Summit Therapeutics (SUMM)

 

SUMM Share PerformanceMore

52 week high262.00 04/10/16
52 week low88.00 16/09/16
52 week change 65.00 (56.52%)
4 week volume226,996 29/04/17

Media for (SUMM)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Summit Announces Key Appointments to Strengthen Research & Development Team

Summit Announces Key Appointments to Strengthen Research & Development Team Summit Therapeutics plc ('Summit' or the 'Company') SUMMIT ANNOUNCES KEY APPOINTMENTS TO STRENGTHEN RESEARCH AND DEVELOPMENT TEAM Dr David Roblin to combine Chief Operating Officer and Chief Medical Officer roles Dr Anne Heathering...

Summit completes PhaseOut DMD enrolment

Summit Therapeutics confirmed the the Company has completed enrolment in PhaseOut DMD, a Phase 2 proof of concep...

Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMD

Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMD Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT COMPLETES ENROLMENT OF PhaseOut DMD, A PHASE 2 CLINICAL TRIAL OF EZUTROMID IN PATIENTS WITH DMD Summit to Receive $22 Million Milestone Payment Oxford, ...

Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases

Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases Summit Therapeutics plc ('Summit', or the 'Company') PHASE 2 CoDIFy TRIAL RESULTS PUBLISHED IN LANCET INFECTIOUS DISEASES WITH DATA SHOWING SUMMIT'S RIDINILAZOLE ACHIEVED STATISTICAL SUPERIORITY OVER VANCOMYCIN I...

Summit Therapeutics plc : Notice of AGM

Summit Therapeutics plc: Notice of AGM Summit Therapeutics plc ("Summit" or the "Company") PUBLICATION OF UK ANNUAL REPORT 2016/17 AND NOTICE OF ANNUAL GENERAL MEETING Oxford, UK, 25 April 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for...

Summit Therapeutics plc : Grant of Share Options

Summit Therapeutics plc: Grant of Share Options Summit Therapeutics plc ("Summit", the "Company", or the "Group") GRANT OF SHARE OPTIONS TO DIRECTORS/PDMRS Oxford, UK, 12 April 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystro...

Summit Therapeutics plc : Exercise of Options

Summit Therapeutics plc: Exercise of Options Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 10 April 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announces ...

Summit Therapeutics File US Annual Report on Form 20-F

Summit Therapeutics File US Annual Report on Form 20-F Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS FILES US ANNUAL REPORT ON FORM 20-F Oxford, UK, 31 March 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne ...

Fundamental DataMore

EPS-44
Dividend yield0 %

Latest discussion posts More

  • Final results out

    DMD drug trial update Q1 2018. Cdif drug Phase 3 to start Q1 2018. High cash burn. May get more up front from Sarepta 2017. DYOR
    29-Mar-2017
    bobsson
  • NEW ARTICLE: Trends and Targets for 6/03/2017

    " FTSE FOR THE WEEK (FTSE:UKX)A Friday was irritating. It's one thing to speculate "all the action will happen at the open", quite another to glance at the FTSE at 8:01am ...
    5-Mar-2017
    II Editor
  • RNS Ridinilazole CDI

    Good RNS today to push sp up around 13% to #1.90. The FDA and EMA have agreed with Summit the parameters for the Phase 3 trials. Essentially the authorities want the Phase 3 ...
    1-Feb-2017
    bobsson

Users' HoldingsMore

Users who hold Summit Therapeutics also hold..
LLOYDS GRP.20%
RANGE RES.19%
ROYAL BANK SCOT16%
SIRIUS MINERALS16%
ROCKHOPPER12%

Codes & Symbols

ISINGB00BN40HZ01
SymbolsSUMM, LSE:SUMM, SUMM.L, SUMM:LN, LON:SUMM, XLON:SUMM